English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine BioTech
Southeast Asian stem cell leader Medeze launches voluntary conditional cash partial offer for 10% stake in SGX-listed Cordlife Group Limited
May 14, 2025 15:00 HKT
雲頂新耀宣佈耐賦康(R)獲得中國國家藥品監督管理局完全批准 全面拓展IgA腎病治療人群
May 07, 2025 18:08 HKT
云顶新耀宣布耐赋康(R)获得中国国家药品监督管理局完全批准 全面拓展IgA肾病治疗人群
May 07, 2025 18:06 HKT
全產業鏈貫通的抗血清頭部平台商:江西生物持續引領行業發展
May 07, 2025 15:37 HKT
全产业链贯通的抗血清头部平台商:江西生物持续引领行业发展
May 07, 2025 15:35 HKT
Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards
May 05, 2025 19:30 HKT
Coya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with Mild to Moderate Frontotemporal Dementia
Apr 25, 2025 15:49 HKT
HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025
Apr 24, 2025 18:43 HKT
君圣泰医药三项创新研究成果即将亮相2025欧肝会(EASL)
Apr 24, 2025 18:35 HKT
Everest Medicines Announces Approval of 'B' Marker Removal from Company's Stock Code by the Hong Kong Stock Exchange
Apr 22, 2025 10:16 HKT
雲頂新耀「摘B」成功 盈利能力與創新價值獲雙重驗證
Apr 22, 2025 10:12 HKT
云顶新耀"摘B"成功 盈利能力与创新价值获双重验证
Apr 22, 2025 10:11 HKT
CIRC: Attained a New High in Fiscal Year 2024
Apr 22, 2025 09:52 HKT
中國同輻2024財年再創新高
Apr 22, 2025 09:25 HKT
中国同辐2024财年再创新高
Apr 22, 2025 09:16 HKT
analytica Vietnam 2025 Concludes with Record-Breaking Attendance and Exhibitor Participation
Apr 16, 2025 23:55 HKT
熊去氧胆小檗碱(HTD1801)一药多效 即将进入商业化新纪元
Apr 15, 2025 08:10 HKT
熊去氧膽小檗堿(HTD1801)一藥多效 即將進入商業化新紀元
Apr 15, 2025 08:10 HKT
Berberine Ursodeoxycholate (HTD1801) Consistently Demonstrates Comprehensive Benefits for Patients with Type 2 Diabetes Mellitus, Approaching NDA
Apr 15, 2025 08:00 HKT
Hebe Biotechnology Appoints Industry Insider Dr. Hannes Hentze as Chief Development Officer to Advance Next-Generation GLP-1 RA Weight Loss Therapy
Apr 10, 2025 12:57 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: